BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 23846904)

  • 1. Autonomic nerve development contributes to prostate cancer progression.
    Magnon C; Hall SJ; Lin J; Xue X; Gerber L; Freedland SJ; Frenette PS
    Science; 2013 Jul; 341(6142):1236361. PubMed ID: 23846904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer progression attributed to autonomic nerve development: potential for therapeutic prevention of localized and metastatic disease.
    Fernández EV; Price DK; Figg WD
    Cancer Biol Ther; 2013 Nov; 14(11):1005-6. PubMed ID: 24025357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic nerve development contributes to prostate cancer progression.
    Bauman J; McVary K
    Asian J Androl; 2013 Nov; 15(6):713-4. PubMed ID: 24077601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
    Ventura S; Evans BA
    Asian J Androl; 2013 Nov; 15(6):715-6. PubMed ID: 24141535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Words of wisdom: Re: Autonomic nerve development contributes to prostate cancer progression.
    Ali A; Pisipati S; Tewari A
    Eur Urol; 2014 Mar; 65(3):665-6. PubMed ID: 24484758
    [No Abstract]   [Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development.
    Dobrenis K; Gauthier LR; Barroca V; Magnon C
    Int J Cancer; 2015 Feb; 136(4):982-8. PubMed ID: 24975135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer. Prostate cancer takes nerve.
    Isaacs JT
    Science; 2013 Jul; 341(6142):134-5. PubMed ID: 23846894
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour microenvironment: Tumours have a lot of nerve.
    Seton-Rogers S
    Nat Rev Cancer; 2013 Sep; 13(9):608-9. PubMed ID: 23903093
    [No Abstract]   [Full Text] [Related]  

  • 10. Urological cancer: Nerves linked to prostate cancer.
    Kirk R
    Nat Rev Clin Oncol; 2013 Sep; 10(9):487. PubMed ID: 23897079
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer: a role for neoneurogenesis in tumour progression?
    Payton S
    Nat Rev Urol; 2013 Sep; 10(9):491. PubMed ID: 23897502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic role of perineural invasion in prostate biopsy].
    Gutiérrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
    Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
    Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
    Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
    Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
    Hsieh CL; Chung LW
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related axonogenesis and neurogenesis in prostate cancer.
    Ayala GE; Dai H; Powell M; Li R; Ding Y; Wheeler TM; Shine D; Kadmon D; Thompson T; Miles BJ; Ittmann MM; Rowley D
    Clin Cancer Res; 2008 Dec; 14(23):7593-603. PubMed ID: 19047084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic study of periprostatic nerve distribution: immunohistochemical differentiation of parasympathetic and sympathetic nerve fibres.
    Ganzer R; Stolzenburg JU; Wieland WF; Bründl J
    Eur Urol; 2012 Dec; 62(6):1150-6. PubMed ID: 22469393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.